purpos
reviewnew
respiratori
virus
discov
recent
year
new
molecular
diagnost
assay
develop
improv
understand
respiratori
viru
infect
articl
review
chang
epidemiolog
virus
hematopoiet
stem
cell
solid
organ
transplant
recent
findingsrespiratori
virus
frequent
detect
transplant
recipi
number
virus
newli
discov
emerg
last
decad
includ
human
metapneumoviru
human
bocaviru
new
human
coronavirus
rhinovirus
human
polyomavirus
new
pandem
strain
influenza
potenti
virus
caus
lower
respiratori
tract
infect
transplant
vari
greatest
human
metapneumoviru
influenza
appear
limit
new
virus
acut
long
term
complic
hematopoiet
solid
organ
transplant
recipi
activ
area
research
summaryrespiratori
viral
infect
frequent
associ
signific
morbid
follow
transplant
therefor
great
clinic
epidemiolog
interest
new
virus
discov
sensit
diagnost
method
develop
defin
full
impact
emerg
respiratori
virus
transplant
recipi
must
elucid
welldesign
clinic
studi
respiratori
virus
caus
potenti
sever
complic
solid
organ
sot
hematopoiet
stem
cell
transplant
hct
within
last
decad
new
respiratori
tract
pathogen
includ
human
metapneumoviru
hmpv
human
bocaviru
hbov
new
human
coronavirus
new
speci
rhinoviru
hrvc
ki
wu
polyomavirus
kipyv
wupyv
discov
howev
epidemiolog
clinic
characterist
virus
yet
fulli
describ
particularli
transplant
recipi
addit
new
pandem
strain
influenza
emerg
alter
usual
season
influenza
contribut
chang
epidemiolog
influenza
virus
transplant
advanc
field
diagnost
virolog
significantli
driven
influenza
pandem
mani
clinic
laboratori
develop
new
molecular
assay
diagnos
respiratori
virus
similarli
fda
approv
first
multiplex
pcr
assay
detect
respiratori
viru
nucleic
acid
provid
opportun
mani
laboratori
expertis
tradit
virolog
diagnos
larg
number
viral
pathogen
multiplex
panel
microarray
develop
alreadi
avail
market
analytespecif
reagent
asr
compar
studi
shown
increas
sensit
realtim
pcr
assay
new
multiplex
panel
compar
tradit
viral
cultur
immunofluoresc
test
respiratori
viru
infect
rvi
may
present
wide
rang
clinic
syndrom
among
transplant
recipi
asymptomat
infect
sever
pneumonia
death
report
rate
infect
progress
lower
respiratori
tract
diseas
vari
viru
part
depend
viral
detect
methodolog
studi
design
tabl
summar
data
prospect
larg
retrospect
publish
studi
rvi
among
hct
recipi
last
year
figur
provid
cumul
incid
estim
recent
prospect
studi
allogen
hct
recipi
gener
rate
progress
lower
respiratori
tract
infect
death
attribut
infect
decreas
compar
earlier
studi
previou
decad
reason
like
multifactori
includ
less
immunosuppress
transplant
regimen
improv
support
care
sensit
diagnost
earli
treatment
strategi
exampl
studi
report
pneumonia
progress
pneumonia
influenza
rsv
specif
note
earli
diagnosi
treatment
upper
respiratori
tract
infect
appear
effect
prevent
lower
tract
diseas
hct
recipi
risk
factor
diseas
progress
pneumonia
includ
infect
earli
transplant
graftversushost
diseas
allogen
hct
myeloabl
condit
although
main
factor
consist
found
confer
increas
risk
lymphopenia
infect
independ
clinic
symptom
specif
viru
often
character
prolong
viral
shed
may
contribut
emerg
antivir
resist
high
rate
nosocomi
acquisit
describ
outbreak
situat
coinfect
viral
bacteri
fungal
agent
complic
infect
respiratori
virus
hct
risk
factor
diseas
progress
well
identifi
solid
organ
transplant
sot
recipi
lung
transplant
recipi
highest
diseas
sever
longterm
impact
relat
rvi
organ
transplant
recipi
may
also
sever
diseas
complic
one
studi
rvi
sot
nonlung
transplant
recipi
found
complic
among
recipi
heart
transplant
follow
liver
kidney
total
rvi
complic
pneumonia
relationship
infect
organ
reject
tabl
provid
overview
recent
relev
studi
rvi
lung
transplant
recipi
highlight
short
longterm
consequ
one
studi
use
luminex
technolog
detect
respiratori
viru
bronchoalveolar
bal
sampl
lung
transplant
recipi
found
associ
rvi
acut
reject
convers
similar
studi
use
pcr
found
respiratori
viru
bal
sampl
acut
reject
associ
viral
detect
howev
detect
respiratori
virus
sampl
patient
acut
reject
associ
wors
lung
function
slower
recoveri
two
retrospect
pediatr
studi
show
associ
rvi
acut
chronic
allograft
reject
rvi
independ
associ
decreas
surviv
one
larg
multicent
cohort
thu
far
firm
associ
yet
establish
rvi
either
acut
reject
chronic
allograft
dysfunct
sot
larg
prospect
studi
comprehens
viral
test
wellcontrol
multivari
model
need
evalu
consequ
improv
diagnost
method
signific
recent
discov
respiratori
virus
elucid
transplant
popul
although
virus
rsv
piv
known
caus
sever
morbid
mortal
immunosuppress
patient
limit
discuss
recent
updat
regard
virus
newli
discov
emerg
last
year
hmpv
close
relat
rsv
caus
upper
sever
lower
respiratori
tract
infect
transplant
asymptomat
shed
may
potenti
occur
although
consist
report
one
prospect
studi
found
hmpv
infect
adult
hematolog
malign
progress
upper
respiratori
infect
pneumonia
casefat
close
studi
hct
recipi
shown
pneumonia
rate
mortal
rate
among
hct
recipi
underw
bal
workup
pulmonari
infiltr
hmpv
detect
bal
sampl
patient
die
acut
respiratori
failur
highlight
potenti
sever
hmpv
pneumonia
sot
recipi
impact
hmpv
mainli
examin
lung
transplant
although
case
report
sever
diseas
describ
follow
liver
renal
transplant
hmpv
infect
found
lung
transplant
recipi
preval
may
higher
nosocomi
outbreak
one
studi
set
commun
outbreak
identifi
hmpv
bal
sampl
patient
clinic
present
vari
asymptomat
infect
sever
diseas
acut
allograft
reject
frequent
hmpvinfect
group
non
hmpvinfect
group
vs
respect
overal
mortal
also
higher
vs
respect
p
anoth
prospect
studi
found
hmpv
infect
frequent
rsv
lung
transplant
caus
much
pneumonia
acut
allograft
dysfunct
vs
respect
rsv
associ
chronic
allograft
dysfunct
month
similarli
anoth
group
report
hmpv
infect
lung
transplant
recipi
associ
acut
allograft
dysfunct
compar
rsv
hbov
small
dna
viru
member
parvovirida
famili
discov
respiratori
sampl
hbov
identifi
respiratori
blood
saliva
stool
sampl
symptomat
immunocompet
children
seroepidemiolog
studi
shown
seroposit
age
although
studi
report
hbov
frequent
patient
respiratori
symptom
asymptomat
individu
role
hbov
respiratori
ill
remain
controversi
number
report
describ
dissemin
hbov
infect
immunocompromis
patient
viru
detect
mani
sampl
type
includ
nasopharyng
aspir
serum
fece
urin
patient
signific
copathogen
also
present
clinic
relev
hbov
detect
unclear
even
detect
hbov
dna
blood
uncertain
signific
appear
uncommon
one
studi
immunocompromis
children
hbov
dna
detect
whole
blood
sampl
patient
without
respiratori
symptom
preliminari
result
larg
prospect
studi
hct
recipi
found
day
cumul
incid
hbov
detect
respiratori
sampl
cohort
hbov
also
detect
serum
sampl
patient
patient
pneumonia
die
respiratori
symptom
mild
absent
hbov
detect
even
pediatr
patient
quantiti
viral
shed
high
fewer
data
avail
regard
hbov
sot
studi
includ
lung
transplant
recipi
symptomat
asymptomat
bal
neg
hbov
anoth
studi
hbov
detect
bal
sampl
adult
respiratori
insuffici
transplant
hct
lung
liver
one
larg
prospect
studi
lung
transplant
recipi
found
nasopharyng
swab
none
simultan
bal
sampl
posit
hbov
summari
addit
data
need
determin
whether
hbov
play
pathogen
role
hematopoiet
solid
organ
transplant
hcov
rna
virus
member
coronavirida
famili
hcov
long
known
agent
common
cold
hcov
discov
associ
upper
lower
respiratori
tract
infect
infant
older
adult
data
hcov
hct
recipi
limit
recent
report
describ
day
incid
hcov
patient
among
allogen
hct
recipi
patient
prolong
shed
week
interestingli
studi
hcov
infect
associ
presenc
respiratori
symptom
detect
bal
sampl
patient
die
respiratori
failur
also
influenza
hmpv
detect
simultan
four
case
lower
respiratori
tract
infect
describ
includ
fatal
infect
adult
hct
patient
thu
hcov
may
occasion
caus
lower
respiratori
tract
diseas
hct
overal
progress
rate
seem
low
hcov
identifi
sot
recipi
clinic
outcom
specif
investig
studi
mostli
hospit
children
respiratori
symptom
children
hematolog
malign
one
kidney
transplant
recipi
hcov
detect
sole
respiratori
pathogen
prospect
studi
adult
hospit
respiratori
diseas
bal
test
nonsar
hcov
found
posit
patient
receiv
lung
transplant
patient
identifi
etiolog
respiratori
symptom
studi
lung
transplant
recipi
found
hcov
sampl
specif
analysi
symptom
outcom
perform
studi
need
understand
pathogenesi
hcov
immun
respons
immunosuppress
sot
recipi
hrv
rna
virus
member
picornavirida
famili
divid
group
b
recent
describ
c
subdivid
subtyp
new
hrvc
group
associ
higher
rate
pneumonia
asthma
exacerb
children
howev
other
found
ill
sever
hrvc
compar
hrva
hct
recipi
rhinoviru
describ
possibl
caus
lrti
found
bal
patient
although
case
signific
copathogen
two
fatal
case
report
mortal
directli
attribut
rhv
infect
pediatr
patient
hematolog
malign
hct
infect
hrv
one
infect
hrvc
die
respiratori
insuffici
larg
prospect
studi
allogen
hct
recipi
hrv
day
cumul
incid
patient
hrvinfect
patient
concurr
second
respiratori
viru
median
durat
viral
shed
week
patient
shed
hrv
month
posit
hrv
sampl
within
last
week
significantli
associ
multipl
respiratori
symptom
progress
lrti
uncommon
compar
respiratori
virus
patient
posit
hrv
bal
subsequ
die
prospect
studi
lung
transplant
recipi
identifi
rhinoviru
bal
sampl
patient
three
patient
report
persist
rhv
shed
month
three
allograft
dysfunct
two
die
anoth
studi
found
hrv
incid
among
adult
lung
transplant
recipi
presenc
low
hrv
amount
bal
associ
clinic
symptom
contrast
consist
observ
presenc
high
viral
load
studi
need
investig
risk
factor
hrv
diseas
sever
transplant
recipi
particularli
associ
hrvc
infect
kipyv
wupyv
two
new
human
polyomavirus
describ
simultan
detect
respiratori
specimen
seropreval
children
adult
approxim
virus
symptom
yet
clearli
associ
virus
immunocompet
popul
data
avail
transplant
recipi
suspect
virus
establish
latenc
reactiv
immunosuppress
similar
polyomavirus
hct
recipi
serial
nasopharyng
aspir
sampl
posit
one
viru
without
associ
symptom
anoth
studi
report
higher
incid
kipyv
respiratori
sampl
hct
recipi
acut
respiratori
ill
wupyv
detect
preliminari
result
prospect
studi
hct
recipi
found
kipyv
wupyv
nasal
wash
sampl
patient
respect
although
posit
episod
last
mani
week
virus
detect
high
copi
number
patient
detect
associ
presenc
seriou
respiratori
symptom
cohort
cohort
lung
transplant
recipi
bal
sampl
kipyv
wupyv
detect
patient
respect
posit
sampl
associ
observ
presenc
either
viru
acut
reject
whether
virus
trigger
reject
whether
reject
episod
lead
viru
reactiv
remain
clarifi
investig
need
determin
signific
virus
follow
transplant
sinc
emerg
pandem
influenza
strain
comparison
virul
transmiss
season
immunocompet
patient
demonstr
signific
differ
hct
recipi
incid
season
influenza
report
significantli
higher
outbreak
situat
pandem
describ
hct
recipi
oncolog
patient
sever
studi
case
seri
tabl
casefat
rate
rang
variou
cohort
factor
associ
sever
diseas
includ
profound
lymphopenia
increas
age
preexist
lung
diseas
bacteri
coinfect
delay
antivir
hour
initi
symptom
recent
studi
hct
recipi
found
although
differ
mortal
infect
significantli
associ
pneumonia
hypoxemia
prolong
viral
shed
compar
season
influenza
importantli
multivari
model
even
delay
administr
antivir
shown
protect
prevent
pneumonia
corticosteroid
mgkg
associ
reduc
risk
mechan
ventil
one
case
report
describ
detect
influenza
rna
plasma
patient
respiratori
failur
suggest
may
biomark
sever
diseas
tabl
highlight
studi
describ
sot
recipi
mani
case
report
highlight
vari
sever
diseas
among
specif
solid
organ
recipi
gener
death
rate
appear
consist
lower
sot
hct
recipi
although
one
report
describ
signific
mortal
lung
transplant
delay
antivir
therapi
hour
diabet
mellitu
identifi
risk
factor
poor
outcom
largest
sot
studi
includ
patient
center
kidney
liver
lung
heart
organ
allograft
transplant
adult
risk
pneumonia
death
children
children
significantli
like
adult
receiv
antivir
therapi
within
hour
studi
complic
rate
similar
lung
organ
transplant
recipi
influenza
resist
antivir
drug
import
epidemiolog
clinic
concern
case
resist
quickli
emerg
pandem
nearli
resist
strain
substitut
neuraminidas
protein
mutat
observ
develop
within
hour
exposur
oseltamivir
although
oseltamivir
resist
rate
estim
gener
popul
resist
may
develop
half
hct
recipi
indic
studi
serial
posit
influenza
sampl
test
found
develop
mutat
initi
therapi
varieti
outcom
among
hct
recipi
oseltamivirresist
describ
benign
upper
respiratori
infect
sever
fatal
pneumonia
commun
nosocomi
transmiss
describ
immunocompet
immunocompromis
popul
newli
discov
respiratori
virus
hmpv
hbov
human
polyomavirus
new
virus
pandem
influenza
caus
spectrum
ill
patient
transplant
advanc
molecular
diagnost
data
rapidli
emerg
regard
overal
morbid
associ
infect
hmpv
appear
caus
similar
spectrum
diseas
rsv
potenti
sever
pneumonia
recent
studi
suggest
lower
respiratori
tract
diseas
appear
uncommon
although
possibl
coronaviru
rhinoviru
even
rarer
bocaviru
polyomaviru
infect
studi
need
determin
longterm
sequela
respiratori
viru
infect
transplant
defin
clinic
manifest
associ
new
virus
hbov
kipyv
wupyv
delay
antivir
therapi
lymphopenia
consist
associ
sever
diseas
seem
caus
increas
diseas
sever
compar
season
influenza
hct
recipi
develop
oseltamivirresist
immunocompromis
patient
concern
highlight
need
optim
manag
earli
aggress
therapi
close
monitor
welldesign
studi
essenti
fulli
character
epidemiolog
longterm
sequela
respiratori
virus
treatment
prevent
strategi
develop
highli
immunosuppress
transplant
recipi
new
molecular
diagnost
assay
greatli
improv
understand
impact
respiratori
viru
infect
hematopoiet
stem
cell
solid
organ
transplant
recipi
human
metapneumoviru
infect
similar
outcom
rsv
infect
hematopoiet
stem
cell
transplant
recipi
includ
potenti
sever
fatal
pneumonia
rhinoviru
coronaviru
infect
frequent
transplant
recipi
lower
respiratori
tract
diseas
occasion
occur
uncommon
human
bocaviru
new
human
polyomavirus
wupyv
kipyv
present
respiratori
tract
transplant
recipi
signific
respiratori
ill
overal
clinic
impact
still
unknown
pandem
potenti
rapid
emerg
oseltamivir
resist
associ
signific
morbid
highli
immunocompromis
transplant
recipi
particularli
patient
lymphopenia
delay
antivir
therapi
associ
respiratori
viru
infect
acut
chronic
allograft
reject
lung
transplant
recipi
remain
controversi
day
posttransplant
cumul
incid
estim
confid
interv
hrv
hcov
rsv
piv
hadv
influenza
b
hmpv
hrv
human
rhinovirus
hcovhuman
coronavirus
rsv
respiratori
syncyti
viru
piv
parainfluenza
viru
hadv
human
adenovirus
flu
influenza
hmpv
human
metapneumoviru
tabl
respiratori
viru
infect
among
cohort
asymptomat
andor
symptomat
patient
hematopoiet
stem
cell
transplant
andor
hematolog
malign
